PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
36.43%
Net income growth under 50% of MRVL's 88.60%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
3.57%
D&A growth well above MRVL's 0.81%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
74.63%
Slight usage while MRVL is negative at -83.92%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
-153.73%
Both reduce yoy inventory, with MRVL at -2.88%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
No Data
No Data available this quarter, please select a different quarter.
6505.72%
Some yoy usage while MRVL is negative at -231.22%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-53.53%
Negative yoy while MRVL is 387.00%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
14.80%
Operating cash flow growth below 50% of MRVL's 137.99%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-65.26%
Negative yoy CapEx while MRVL is 36.48%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-51.20%
Both yoy lines negative, with MRVL at -822.76%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-8.03%
We reduce yoy sales while MRVL is 67.83%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-222.09%
Both yoy lines negative, with MRVL at -138.79%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-15.68%
Negative yoy issuance while MRVL is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-0.53%
We cut yoy buybacks while MRVL is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.